Francis Baumgartner

6PUBLICATIONS
42CO-AUTHORS
Solid tumoursMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2026
CAR transgenic T-cell lymphoproliferative neoplasm (CTTLN): malignant transformation of cellular immunotherapy.

|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.

Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg

|Feb 20, 2024
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

|Dec 08, 2023
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.

Francis Baumgartner, Constance Baer, Stefanos Bamopoulos

|Aug 02, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.

Guus J J E Heynen, Francis Baumgartner, Michael Heider

Pageof 1

Frequent Collaborators

5 joint publications

Ulrich Keller

3 joint publications

Jan Braune

3 joint publications

Stefanos Bamopoulos

3 joint publications

Jan Krönke